AI-generated summary
The authors developed Cu3BiS3 nanocrystals that absorb near-infrared light and tested them in vivo for photodynamic therapy and x-ray tumor imaging. They report complete tumor regression after ultra-low dose near-infrared laser treatment without an added photosensitizer. The abstract describes the work as preliminary and the nanocrystals as promising candidates, but does not state sample sizes or controls.
- Who or what was studied
- Tumor-bearing animals (in vivo model; species and number not stated in the abstract)
- Limits stated in the abstract
- The abstract does not report sample size, control groups, or the species used, and describes the results as preliminary candidates rather than established treatments.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on thno.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Near-infrared, Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.